CEO unhappy at level of co-operation between the government and private sector in developing health-care strategy
South African multinational says the deal will give the government access to competitively priced active pharmaceutical ingredients
In its financial year to end-June, the investment holding company concluded four acquisitions
Maker of OxyContin aims to declare bankruptcy once it has a settlement, insiders say, but some US states are resisting
Group CE Adrian Gore and his executive team present Discovery’s annual financial results live
NMT Capital has accused Old Mutual of using it as a proxy in its battle with Peter Moyo, accusing the life insurer of insulting behaviour and pettiness
Market cheers company’s strong cash flow and better-than-expected gearing
Blue-chip drugmaker is selling off noncore assets to deal with its debt mountain
Pharmaceutical company delivers robust results and improves profits in the year to end-June
Group says medical schemes will probably continue operating alongside National Health Insurance
Changing the healthcare system to one centred on a Fund that will purchase services on behalf of the entire population is sending shivers in the sector
Discovery’s share price closed at R105.72, down 8.44%, the second day of big losses for the share since the long-awaited NHI bill was unveiled by government on ...
Battle highlights the conundrum facing all three JSE-listed hospital groups, as they face regulatory constraints to domestic expansion and have struggled to ...
Decision seen as unusual given that medical schemes industry is consolidating
But RH Bophelo says it not have any employees, as staffing is under the care of RH Bophelo Management Company
Ascendis has also been in talks about a possible sale of its Remedica business in Cyprus, which is seen as key to reducing Ascendis’s debt